Vertaling van "combined risk " (Nederlands → Frans) :

TERMINOLOGIE

combined hepatocellular carcinoma and cholangiocarcinoma
hépatocholangiocarcinome

'severe combined immunodeficiency' [SCID] met lage of normale aantallen B-cellen
Déficit immunitaire combiné sévère [DICS] avec nombre faible ou normal de cellules B

'severe combined immunodeficiency' [SCID] met lage aantallen T- en B-cellen
Déficit immunitaire combiné sévère [DICS] avec nombre faible de cellules B et T

'severe combined immunodeficiency' [SCID] met reticulaire dysgenese
Déficit immunitaire combiné sévère [DICS] avec dysgénésie réticulaire

'severe combined immunodeficiency' [SCID] NNO
Déficit immunitaire combiné sévère [DICS] SAI

controle van zwangerschap met verhoogd risico [high-risk]
Surveillance d'une grossesse à haut risque

IN-CONTEXT TRANSLATIONS

1A).7, 8 shows the danger of combined risk factors, as these tend to interact: all three for stroke important risk factors give you the stroke risk of a person that is not less than 32 years older.
7, 8 Figure 2 shows the danger of combined risk factors, as these tend to interact: all three for stroke important risk factors give you the stroke risk of a person that is not less than 32 years older.

some contexts in which these beverages are consumed (sports activities, in combination with alcohol) have been associated with a cardiovascular risk whilst exerting physical effort as well as a risk of lessened perception of the effects of alcohol. However, objectively, the latter remain intact.
certaines situations d’emploi de la boisson (activité sportive, prise concomitante d’alcool) sont associées d’une part à un risque cardio-vasculaire à l’exercice et, d’autre part, à un risque de perception amoindrie des effets de l’alcool qui demeurent toutefois.

26. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery.
25. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery.

Lotrel (USD 386 million, –48% lc, only in the US), a single-pill combination therapy for high blood pressure, fell sharply after an “at risk” launch in mid-2007 by a generic competitor despite a US patent valid until 2017.
Lotrel (USD 386 millions, -48% en m. l. aux USA uniquement), traitement hypotenseur combiné en un seul comprimé, a subi depuis la mi-2007 une baisse due au lancement d’un générique par un concurrent qui a pris un risque, car le brevet américain est valable jusqu’en 2017.